Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GSK doubles down on Zymeworks’ platform technologies with $908M deal
GSK doubles down on Zymeworks’ platform technologies with $908M deal
GSK doubles down on Zymeworks’ platform technologies with $908M deal
Submitted by
admin
on April 27, 2016 - 9:23am
Source:
Fierce Biotech
News Tags:
GSK
Zymeworks
R&D
bispecific antibodies
drug development
Headline:
GSK doubles down on Zymeworks’ platform technologies with $908M deal
Do Not Allow Advertisers to Use My Personal information
